Apple and Alibaba announced that Qwen will be integrated into the China edition of Apple Intelligence, with developer Beta testing starting November 4 and a rollout via iOS 27.3 in December. The integration will power Siri, Writing Tools, and Visual Intelligence for users in China while giving users control over activation and data sharing.
An NAACP lawsuit accuses the SpaceX-owned AI company of violating the Clean Air Act.
On November 4 at Boston’s SoWa Power Station, get ready for a full day packed with meaningful networking opportunities, actionable insights, and connections that could change the trajectory of your idea and startup. Register before all prices go up at the door.
Apple's new CEO defended the company's current position in the AI landscape.
WDCD Run #406 (2026-11-01) measured instruction decay across 15 frontier AI models over three dialogue rounds, with Gemini 3.1 Pro leading at 91 points and the only top-tier model exhibiting negative decay (-63%), indicating strengthened constraint adherence under pressure.
In the latest WDCD v3.1 test, only DeepSeek V4 Pro and GPT-6.1 Sol improved, while 12 of 15 models declined; Qwen3 Max fell 26.2 points. Gemini 3.1 Pro remained first with 91.00 points despite a slight 3-point drop.
The WDCD v3.1 five-scenario benchmark shows Data Boundaries as the hardest scenario, with qwen3-max scoring just 1.36/4, while Engineering Compliance reaches a rare 4/4 from gemini-3.1-pro. Eight models show significant scenario-specific imbalances.
On the v2 anchor questions, Qwen3 Max fully collapses in 30.8% of its R3 runs while Grok 4 records zero collapses, exposing how constraint-keeping decays across three escalating rounds of pressure.
In the WDCD v3.1 constraint-adherence test, Gemini 3.1 Pro tops the ranking with 91.00 points while Qwen3 Max finishes last at 58.85, a 32.15-point spread. The top five cluster within 8.29 points, while the bottom five fall away sharply.
OpenAI has released a compilation of excerpts from 12 amicus briefs arguing that AI training is fair use, timed to the deadline in the consolidated copyright case against The New York Times. The case tests whether fair use can shield LLM training as courts weigh market substitution and diverging precedents.
New York's RAISE Act opens its registration window in November 2026, requiring frontier AI developers with more than $500 million in annual revenue and models trained with over 10^26 operations to register with the state's DIGIT office. The law marks a shift from voluntary commitments to binding state-level AI regulation, though key enforcement details remain undefined.
In today's Smoke evaluation, GPT-o3's Material Constraints score fell 25 points while Code Execution rose 20.1 points, leaving the main leaderboard down only 0.2 points. The swing is most likely due to small-sample item-draw variance rather than systematic model degradation.
In the latest Smoke evaluation, Grok 4's code execution score fell 15.8 points while material constraints rose 16.9 points, leaving the main leaderboard down only 1.1 points. The mirror-opposite moves and small daily sample point to question-sampling volatility rather than a systemic capability decline.
In the seven-day Smoke evaluation from October 26 to November 1, 2026, Claude Opus 4.7 posted the largest upward trend at 47.8 points and a final-day score of 98.79, while GPT-6.1 Sol remained flat at 86 points with a 0 trend and an 82.5 average.
The 2026-11-01 YZ Index Smoke test covered 13 models, with Claude Opus 4.7 taking the top spot for the day at 98.79 points. The Smoke test is a daily 10-question quick assessment intended for short-term signals, not for final conclusions about model capability.
OpenAI’s latest funding round doesn't seem to be living up to expectations.
Named “Volta-Autodoxer,” the recently uncovered malware uses AI tools to collect troves of data about victims, from login credentials and credit card numbers to Discord sessions and UberEats receipts.
Companies have spent the past several weeks trying to reassure investors that Muse and other AI agents pose more of an opportunity than a threat.
A biotech startup let an agent choose a gene therapy and successfully inject the treatment, offering a startling glimpse of the future of research labs.
When investors get nervous about AI spending, it helps to have the chipmaker that sells the chips offer to cosign the loan.
